ZYLö THERAPEUTICS

Zylö Therapeutics offers an innovative sustained-release drug-delivery system that was developed by Joel Friedman MD PhD, Adam Friedman MD FAAD, and Andrew Draganski PhD. The delivery system uses patented hydrogel-derived nanoparticles, called Nanopods, to deliver—in a sustained and controlled manner—notoriously hard-to-deliver therapeutic agents through topical administration. The company was founded in 2017 and is based in Greenville, South Carolina.

#SimilarOrganizations #People #Financial #Website #More

ZYLö THERAPEUTICS

Social Links:

Facebook

Linkedin

Industry:

Health Care Pharmaceutical Therapeutics

Founded:

2017-11-01

Address:

Greenville, South Carolina, United States

Country:

United States

Website Url:

http://www.zylotherapeutics.com

Total Employee:

11+

Status:

Active

Contact:

858.775.6710

Email Addresses:

[email protected]

Total Funding:

13.19 M USD

Technology used in webpage:

Viewport Meta IPhone / Mobile Compatible SSL By Default Apple Mobile Web Clips Icon Content Delivery Network Euro Microsoft Exchange Online Google GStatic Google Static Content Google Cloud

Similar Organizations

apellis-pharmaceuticals-logo

Apellis Pharmaceuticals

Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.

blade-therapeutics-logo

Blade Therapeutics

Blade Therapeutics is a discovery stage drug development company.

geneos-therapeutics-logo

Geneos Therapeutics

Geneos Therapeutics is a developer of a neo-antigen based personalized immunotherapy designed to offer cancer treatment.

Current Advisors List

gary-atkinson_image

Gary Atkinson Board Member @ Zylö Therapeutics
Board_member
2017-01-01

not_available_image

James Cordes Board Member @ Zylö Therapeutics
Board_member
2022-06-03

matthew-dunbar_image

Matthew Dunbar Board of Directors @ Zylö Therapeutics
Board_member
2019-10-01

Current Employees Featured

scott-r-pancoast_image

Scott R. Pancoast
Scott R. Pancoast CEO @ Zylö Therapeutics
CEO

michael-rabin_image

Michael Rabin
Michael Rabin VP of Strategy @ Zylö Therapeutics
VP of Strategy
2020-09-01

Founder

scott-r-pancoast_image

Scott R. Pancoast

Investors List

new-york-angels_image

New York Angels

New York Angels investment in Series B - Zylö Therapeutics

james-cordes_image

James Cordes

James Cordes investment in Series B - Zylö Therapeutics

harvard-business-school-alumni-angels-of-greater-ny_image

Harvard Business School Alumni Angels of Greater NY

Harvard Business School Alumni Angels of Greater NY investment in Series B - Zylö Therapeutics

cowtown-angels_image

Cowtown Angels

Cowtown Angels investment in Series B - Zylö Therapeutics

sc-launch_image

SC Launch, Inc.

SC Launch, Inc. investment in Series B - Zylö Therapeutics

boston-harbor-angels_image

Boston Harbor Angels

Boston Harbor Angels investment in Series B - Zylö Therapeutics

south-carolina-angel-network_image

VentureSouth

VentureSouth investment in Series B - Zylö Therapeutics

sc-launch_image

SC Launch, Inc.

SC Launch, Inc. investment in Grant - Zylö Therapeutics

national-institute-of-diabetes-and-digestive-and-kidney-diseases_image

National Institute of Diabetes and Digestive and Kidney Diseases

National Institute of Diabetes and Digestive and Kidney Diseases investment in Grant - Zylö Therapeutics

national-institute-of-diabetes-and-digestive-and-kidney-diseases_image

National Institute of Diabetes and Digestive and Kidney Diseases

National Institute of Diabetes and Digestive and Kidney Diseases investment in Grant - Zylö Therapeutics

Official Site Inspections

http://www.zylotherapeutics.com

Host Informations
Whois Informations

Loading ...

More informations about "Zylö Therapeutics" on Search Engine